In addition, nuclear matrix protein 22 (NMP22), bladder tumor antigen (BTA), fluorescence in situ hybridization (FISH) and other detection techniques have become screening tools for bladder cancer (Brausi et al., 2011; Wood, 2014). This evidence concerns the gene NUMA1 and urinary bladder carcinoma.